Institutional & Family Asset Management’s Blueprint Medicines BPMC Stock Holding History

Institutional & Family Asset Management’s Portfolio BPMC Stock Details BPMC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	$970	Hold	9	–	–	﹤0.01%	648
2024 Q1	$854	Hold	9	–	–	﹤0.01%	651
2023 Q4	$830	Hold	9	–	–	﹤0.01%	631
2023 Q3	$452	Buy	9 +4	+80%	+$214	﹤0.01%	673
2023 Q2	$316	Hold	5	–	–	﹤0.01%	714
2023 Q1	$225	Hold	5	–	–	﹤0.01%	712
2022 Q4	$219	Hold	5	–	–	﹤0.01%	694
2022 Q3	$0	Sell	5 -4	-44%	-$257	﹤0.01%	712
2022 Q2	$0	Hold	9	–	–	﹤0.01%	729
2022 Q1	$1K	Hold	9	–	–	﹤0.01%	678
2021 Q4	$1K	Hold	9	–	–	﹤0.01%	703
2021 Q3	$1K	Sell	9 -6	-40%	-$559	﹤0.01%	820
2021 Q2	$1K	Hold	15	–	–	﹤0.01%	874
2021 Q1	$1K	Sell	15 -9	-38%	-$899	﹤0.01%	844
2020 Q4	$3K	Sell	24 -1	-4%	-$105	﹤0.01%	691
2020 Q3	$2K	Buy	25 +7	+39%	+$539	﹤0.01%	676
2020 Q2	$1K	Sell	18 -6	-25%	-$406	﹤0.01%	754
2020 Q1	$1K	Hold	24	–	–	﹤0.01%	710
2019 Q4	$2K	Hold	24	–	–	﹤0.01%	710
2019 Q3	$2K	Sell	24 -1	-4%	-$86	﹤0.01%	669
2019 Q2	$2K	Hold	25	–	–	﹤0.01%	692
2019 Q1	$2K	Hold	25	–	–	﹤0.01%	695
2018 Q4	$1K	Hold	25	–	–	﹤0.01%	749
2018 Q3	$2K	Buy	+25	New	+$1.74K	﹤0.01%	717

Other funds holding BPMC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Institutional & Family Asset Management's BPMC Position: Q2 2024 in Review

Institutional & Family Asset Management held its Blueprint Medicines (BPMC) position steady in Q2 2024 at 9 shares worth $970. The position accounts for ﹤0.01% of the portfolio, ranked #648.

Institutional & Family Asset Management first reported a position in BPMC in Q3 2018 and has held it in 24 quarters since. The position peaked at $3K in Q4 2020. 305 funds tracked by Wall St. Rank hold BPMC as of Q2 2024.

Institutional & Family Asset Management held 9 shares of Blueprint Medicines worth $970 as of Q2 2024.
Institutional & Family Asset Management left its Blueprint Medicines share count unchanged in Q2 2024.
Blueprint Medicines made up ﹤0.01% of Institutional & Family Asset Management's portfolio in Q2 2024, its #648 holding.
Institutional & Family Asset Management first reported a position in Blueprint Medicines in Q3 2018 and has held it in 24 quarters since.
Institutional & Family Asset Management's Blueprint Medicines position peaked at $3K in Q4 2020.
305 funds tracked by Wall St. Rank held Blueprint Medicines as of Q2 2024.

Based on Institutional & Family Asset Management's 13F filing for Q2 2024, filed 5 Jul 2024.